Dima A. Sabbah

2.1k total citations · 1 hit paper
83 papers, 1.5k citations indexed

About

Dima A. Sabbah is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Dima A. Sabbah has authored 83 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 22 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Dima A. Sabbah's work include PI3K/AKT/mTOR signaling in cancer (21 papers), Synthesis and biological activity (13 papers) and Computational Drug Discovery Methods (13 papers). Dima A. Sabbah is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (21 papers), Synthesis and biological activity (13 papers) and Computational Drug Discovery Methods (13 papers). Dima A. Sabbah collaborates with scholars based in Jordan, United States and Saudi Arabia. Dima A. Sabbah's co-authors include Rima Hajjo, Kamal Sweidan, Sanaa K. Bardaweel, Haizhen A. Zhong, Jonathan L. Vennerstrom, Reema Abu Khalaf, Ghassan Abu Sheikha, Alexander Tropsha, Michael G. Brattain and Abdel Qader Al Bawab and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Life Sciences.

In The Last Decade

Dima A. Sabbah

81 papers receiving 1.5k citations

Hit Papers

Review on Epidermal Growth Factor Receptor (EGFR) Structu... 2020 2026 2022 2024 2020 100 200 300

Peers

Dima A. Sabbah
Tove Tuntland United States
Qiu Sun China
Nam Doo Kim South Korea
Hong Ding China
Scott J. Weir United States
Dima A. Sabbah
Citations per year, relative to Dima A. Sabbah Dima A. Sabbah (= 1×) peers Pankaj Kumar Singh

Countries citing papers authored by Dima A. Sabbah

Since Specialization
Citations

This map shows the geographic impact of Dima A. Sabbah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dima A. Sabbah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dima A. Sabbah more than expected).

Fields of papers citing papers by Dima A. Sabbah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dima A. Sabbah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dima A. Sabbah. The network helps show where Dima A. Sabbah may publish in the future.

Co-authorship network of co-authors of Dima A. Sabbah

This figure shows the co-authorship network connecting the top 25 collaborators of Dima A. Sabbah. A scholar is included among the top collaborators of Dima A. Sabbah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dima A. Sabbah. Dima A. Sabbah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabbah, Dima A., Rima Hajjo, Hiba Zalloum, et al.. (2025). Exploring Carboxamide Derivatives as Promising Anticancer Agents: Design, In Vitro Evaluation, and Mechanistic Insights. International Journal of Molecular Sciences. 26(12). 5903–5903. 3 indexed citations
2.
Ramírez, Karol, Dima A. Sabbah, Camille Goemans, et al.. (2025). Human Atlas of Tooth Decay Progression: Identification of Cellular Mechanisms Driving the Switch from Dental Pulp Repair Toward Irreversible Pulpitis. Advanced Science. 13(8). e10096–e10096.
3.
Hajjo, Rima, et al.. (2025). Advancing the understanding and management of Mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies. BMC Infectious Diseases. 25(1). 529–529. 8 indexed citations
6.
Sabbah, Dima A., et al.. (2024). Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012–2024). Molecules. 30(1). 126–126. 3 indexed citations
7.
Hajjo, Rima, et al.. (2023). Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases. Viruses. 15(2). 568–568. 12 indexed citations
9.
Hajjo, Rima, et al.. (2023). Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes. npj Vaccines. 8(1). 129–129. 8 indexed citations
10.
Sabbah, Dima A.. (2023). Progress in the Design and Development of Phosphoinositide-3-Kinase (PI3Kα) Inhibitors. Jordan Journal of Pharmaceutical Sciences. 16(2). 450–450. 1 indexed citations
11.
Sabbah, Dima A., et al.. (2021). Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development. Molecules. 26(19). 6019–6019. 49 indexed citations
12.
Khalaf, Reema Abu, et al.. (2021). Discovery, synthesis and in combo studies of Schiff’s bases as promising dipeptidyl peptidase-IV inhibitors. Molecular Diversity. 26(2). 1213–1225. 4 indexed citations
13.
Mahmoud, Nouf N., et al.. (2020). Gold Nanocomplex Strongly Modulates the PI3K/Akt Pathway and Other Pathways in MCF-7 Breast Cancer Cell Line. International Journal of Molecular Sciences. 21(9). 3320–3320. 15 indexed citations
14.
Sabbah, Dima A., Kamal Sweidan, Sanaa K. Bardaweel, et al.. (2018). Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents. Anti-Cancer Agents in Medicinal Chemistry. 18(2). 263–276. 24 indexed citations
15.
Sabbah, Dima A. & Haizhen A. Zhong. (2016). Modeling the protonation states of β-secretase binding pocket by molecular dynamics simulations and docking studies. Journal of Molecular Graphics and Modelling. 68. 206–215. 20 indexed citations
16.
Khalaf, Reema Abu, et al.. (2016). Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors. Medicinal Chemistry. 13(3). 239–253. 15 indexed citations
17.
Sabbah, Dima A., Reema Abu Khalaf, Sanaa K. Bardaweel, et al.. (2015). Molecular modeling based approach, synthesis, and cytotoxic activity of novel benzoin derivatives targeting phosphoinostide 3-kinase (PI3Kα). Bioorganic & Medicinal Chemistry Letters. 25(16). 3120–3124. 28 indexed citations
18.
Sabbah, Dima A., Wang Wang, Yuxiang Dong, et al.. (2012). N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα). Bioorganic & Medicinal Chemistry. 20(24). 7175–7183. 31 indexed citations
19.
Sabbah, Dima A., et al.. (2011). Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases. Bioorganic & Medicinal Chemistry Letters. 22(2). 876–880. 29 indexed citations
20.
Sabbah, Dima A., et al.. (1969). Synthesis, Structural Characterization and Docking Studies of Sulfamoyl-Phenyl Acid Esters as DPP-IV Inhibitors. Current Computer - Aided Drug Design. 14. 1–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026